Tus kws kho mob
P65-17 Clarification to Commercial Prior Authorization for Biologic Immunomodulators
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 06, 2017
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2881 - 2890 ntawm 4179
Tus kws kho mob
P39R1-18 Update: Blue Cross Contracts with eviCore to Expand Utilization Management for Post-Acute Care
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 01, 2018
Tus kws kho mob
P2-18 New Medical Drug PA Requirements for Voretigene Neparvovec (Luxturna)
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 11, 2018
Tus kws kho mob
P11-18 Minnesota Health Care Programs (MHCP) Reimbursement Rate for Vaccine Administration
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 02, 2018
Tus kws kho mob
P41-17 PCA Agencies Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 17, 2017
Tus kws kho mob
P40-17 New Prior Authorization Requirements for Immunomodular Drugs
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 12, 2017
Tus kws kho mob
P20-18 2018 Renewal Changes Summary For Blue Plus Referral Health Professional Providers
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2018
Tus kws kho mob
P38-17 New Drug-Related Prior Authorization (PA) for Xolair
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 05, 2017
Tus kws kho mob
P28-18 Change to Administration of Interpreter Services for MHCP Subscribers
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 28, 2018
Tus kws kho mob
2018 July Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 02, 2018